IWP
ABBV icon

Icon Wealth Partners’s AbbVie ABBV Stock Holding History

Icon Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$5.66M Sell
37,989
-4,952
-12% -$727K 0.64% 28
2023
Q2 		$5.79M Sell
42,941
-4,165
-9% -$611K 0.61% 27
2023
Q1 		$7.51M Buy
+47,106
New +$7.2M 0.82% 22
2022
Q2 		$7.76M Sell
50,656
-753
-1% -$115K 0.93% 17
2022
Q1 		$8.33M Buy
51,409
+5,447
+12% +$791K 0.83% 21
2021
Q4 		$6.22M Sell
45,962
-2,377
-5% -$281K 0.62% 39
2021
Q3 		$5.21M Sell
48,339
-591
-1% -$67.5K 0.55% 47
2021
Q2 		$5.51M Buy
48,930
+3,363
+7% +$379K 0.59% 44
2021
Q1 		$4.93M Buy
45,567
+8,873
+24% +$949K 0.62% 41
2020
Q4 		$3.93M Buy
36,694
+6,496
+22% +$624K 0.62% 39
2020
Q3 		$2.65M Buy
30,198
+6,918
+30% +$651K 0.51% 53
2020
Q2 		$2.29M Buy
23,280
+19,247
+477% +$1.69M 0.55% 37
2020
Q1 		$307K Buy
4,033
+27
+0.7% +$2.3K 0.12% 97
2019
Q4 		$355K Buy
4,006
+310
+8% +$25.7K 0.11% 103
2019
Q3 		$280K Sell
3,696
-120
-3% -$8.23K 0.1% 120
2019
Q2 		$277K Sell
3,816
-5
-0.1% -$393 0.1% 119
2019
Q1 		$308K Sell
3,821
-1,519
-28% -$124K 0.12% 108
2018
Q4 		$492K Buy
5,340
+1,958
+58% +$172K 0.24% 66
2018
Q3 		$320K Buy
3,382
+572
+20% +$54.2K 0.13% 128
2018
Q2 		$260K Sell
2,810
-117
-4% -$11.4K 0.11% 132
2018
Q1 		$277K Sell
2,927
-606
-17% -$66.6K 0.15% 139
2017
Q4 		$342K Buy
+3,533
New +$333K 0.17% 124

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Icon Wealth Partners's ABBV Position: Q3 2023 in Review

Icon Wealth Partners reduced its AbbVie (ABBV) stake by 12% in Q3 2023, selling an estimated $727K and leaving 37,989 shares worth $5.66M. The position accounts for 0.64% of the portfolio, ranked #28.

Icon Wealth Partners first reported a position in ABBV in Q4 2017 and has held it in 22 quarters since. The position peaked at $8.33M in Q1 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Icon Wealth Partners held 37,989 shares of AbbVie worth $5.66M as of Q3 2023.
  • Icon Wealth Partners sold 4,952 AbbVie shares in Q3 2023, an estimated $727K.
  • AbbVie made up 0.64% of Icon Wealth Partners's portfolio in Q3 2023, its #28 holding.
  • Icon Wealth Partners first reported a position in AbbVie in Q4 2017 and has held it in 22 quarters since.
  • Icon Wealth Partners's AbbVie position peaked at $8.33M in Q1 2022.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.